Wellthy Therapeutics acquired by TruDoc

TruDoc Healthcare, a pioneering virtual primary care provider in the GCC region, has made a groundbreaking move by acquiring Wellthy Therapeutics, the foremost chronic disease management platform in Asia. This strategic merger not only sets new benchmarks for healthcare outcomes, quality, and patient experience but also marks TruDoc's expansion into burgeoning markets like India. The integration of Wellthy Therapeutics' cutting-edge behavioural science and digital therapeutic solutions with TruDoc's extensive virtual and in-home healthcare services heralds the dawn of a transformative era in healthcare delivery. This alliance ensures uninterrupted access to top-notch care, personalized treatment plans, and innovative care delivery methods, promising significant improvements in health outcomes while optimizing healthcare expenditures.

At the core of this combined vision lies a commitment to patient-centric care, aiming to provide a seamless, integrated healthcare experience where patients are the focal point of every decision. Leveraging TruDoc's leadership in the GCC region and Wellthy's established reputation in Asia, this partnership reinforces TruDoc's position as a tech-enabled primary care leader in the region.

Vish Narain, Chairman of TruDoc, stated, “With this acquisition, we are hitting a key milestone on our path to transforming healthcare across the GCC and beyond. We are crafting an integrated care experience that’s tailored to the changing needs of our patients and our clients. We envision a future where primary care is easily accessible, starting with digital platforms, followed by in-home care, with in-clinic visits only when needed.”

“Our founding goal at Wellthy was ambitious; to impact millions of lives. This partnership accelerates our progress towards our impact goal, broadening our reach while enhancing patient outcomes,” stated Abhishek Shah, Founder of Wellthy Therapeutics. “The combined capabilities are uniquely positioned to significantly lower healthcare expenses, contribute to savings, and reduce unnecessary hospital and clinic visits, while substantially improving the patient experience.”

The synergy between TruDoc and Wellthy Therapeutics empowers insurers, employers, and governments to offer high-quality, tailored care. Integrated services encompass connected care, remote monitoring, and instant access to healthcare professionals, all supported by AI-driven personalized care protocols. This holistic approach not only enhances patient care but also demonstrates validated cost reductions across the outpatient care spectrum.

Aligned with Vision 2025, TruDoc and Wellthy Therapeutics are pooling their clinical expertise and digital health proficiency to establish a sustainable healthcare ecosystem aimed at positively impacting 10 million lives. This strategic collaboration represents a significant leap towards achieving comprehensive primary care, leveraging TruDoc's clinical excellence and Wellthy Therapeutics' expertise in digital health and behavioural science.